共 50 条
- [44] Computational modeling of Hsp90 inhibition illustrates a potential therapy to inhibit immune-mediated inflammation in systemic lupus erythematosus JOURNAL OF IMMUNOLOGY, 2010, 184
- [47] Regorafenib and ginsenoside combination therapy: inhibition of HepG2 cell growth through modulating survivin and caspase-3 gene expression Clinical and Translational Oncology, 2020, 22 : 1491 - 1498
- [48] Regorafenib and ginsenoside combination therapy: inhibition of HepG2 cell growth through modulating survivin and caspase-3 gene expression CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (09): : 1491 - 1498